GoodRx vs Hims
GoodRx costs $50 less a month, and both sell tirzepatide.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Hims
Best for: knowing which pharmacy fills the vial: it names Apostrophe Pharmacy LLC
Visit Hims →If you are choosing between GoodRx and Hims, the first difference is cost: GoodRx is $50 a month cheaper at the entry price. Both prescribe tirzepatide, so moving from one to the other would not change your drug. GoodRx leads our six-part score, 6.9 to 6.8. One of the two has an FDA warning letter on record, covered below.
GoodRx vs Hims price
GoodRx is the cheaper way in: $149 a month against $199 a month at Hims. That is $50 less each month (25% lower), or about $600 over a year of treatment.
Drug by drug: Tirzepatide costs the same at both, $299 a month.
Medications and formats
Both sell tirzepatide; only GoodRx lists orforglipron; only Hims lists semaglutide.
On format, GoodRx prices brand-name pens, while Hims prices compounded injections and brand-name pens.
Where each one treats patients
GoodRx lists 50 states, and Hims lists 50 states.
They overlap in 50 states.
Pricing
GoodRx
Hims
Brand Zepbound from $299/mo medication-only; requires Hims Weight Loss Membership ($149/mo)
What each price covers
Hims' price also covers the medication itself, which GoodRx does not claim.
GoodRx does not say what its price includes.
Hims is silent on shipping and lab work.
That matters most for the drug: unless GoodRx confirms otherwise, budget for medication on top of its listed price.
GoodRx
Inclusions not disclosed.
Hims
Covered by the monthly price
Medication
In the price
Clinician visits
Charged on top
Shipping
Not stated
Lab work
Not stated
Coaching
Charged on top
Where each one scores higher
Overall, GoodRx scores 6.9 and Hims 6.8 out of 10.
GoodRx is stronger on value (5.0 vs 3.0) and support (5.0 vs 3.0).
Hims is stronger on user experience (8.0 vs 5.0) and trust & safety (7.0 vs 6.0).
Effectiveness and accessibility are within half a point.
GoodRx
6.9/10
Hims
6.8/10
Value25%
Effectiveness25%
User Experience15%
Trust & Safety15%
Accessibility10%
Support10%
FDA warning letters
The FDA sent Hims a warning letter dated September 9, 2025 (letter 716567), and it is still open.
GoodRx has no FDA warning letter on record with us.
Features & Coverage
| Feature | GoodRx | Hims |
|---|---|---|
| Starting Price | ✓$149/mo | $199/mo |
| Features | ✓6 features | 2 features |
| States Available | 50 | 50 |
| Compounded | — | ✓ Yes |
| Brand Name | ✓ Yes | ✓ Yes |
| FSA/HSA Accepted | — | — |
| FDA Warning Letters | ✓None | 1 letter |
About GoodRx
GoodRx (NASDAQ: GDRX) is the largest US prescription savings platform. It publishes self-pay discount pricing on brand-name GLP-1 medications, with Foundayo (orforglipron) starting at $149/month and the Zepbound KwikPen (tirzepatide) starting at $299/month, redeemable at 70,000+ pharmacies nationwide. It also operates GoodRx Care, a telehealth arm that prescribes GLP-1s with online visits starting at $39.
Read our full GoodRx review →About Hims
Hims is a major men's telehealth brand. Its weight loss offering is compounded semaglutide on a 6-month plan.
Read our full Hims review →Pros & Cons
GoodRx
What we like
- Orforglipron costs $149 a month, close to the $149 median for brand-name orforglipron across the sellers we compare
- Tirzepatide costs $299 a month, 76% below the $1249 median for brand-name tirzepatide across the sellers we compare
- Serves all 50 states
- We found no FDA warning letters issued to GoodRx
Watch-outs
- Ask which pharmacy fills the prescription before you pay, so you can check its license
Hims
What we like
- Shows its price before the medical questionnaire, so you can compare it without handing over health information
- The monthly price includes the medication
- Serves all 50 states
- Names 4 pharmacies that fill its prescriptions, which most sellers do not
Watch-outs
- Not included in the monthly price: clinician visits, coaching
- The FDA has issued Hims a warning letter. Read what it alleges: a letter flags a problem but does not by itself rule a seller out
- Its semaglutide is compounded rather than FDA-approved, so it has not been reviewed by the agency for safety, effectiveness or manufacturing quality
Our Verdict
GoodRx wins this one, 6.9 to 6.8, above all for oral orforglipron alongside the injectables. It also costs $50 less each month than Hims. Hims fits better if knowing which pharmacy fills the vial: it names Apostrophe Pharmacy LLC is your priority.
Choose GoodRx if…
You want oral orforglipron alongside the injectables and an opening price near $149 a month.
Choose Hims if…
You want knowing which pharmacy fills the vial: it names Apostrophe Pharmacy LLC and an opening price near $199 a month.
Ready to start? GLP-1 providers we have vetted
Telehealth providers, vetted by us, prescribing GLP-1 online.
Vetted by our editors · no insurance required
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
He & She MD
Starting below a standard dose, with microdose tiers
From $99/mo
Get started →Wellorithm
Compounded semaglutide at $247/month
From $247/mo
Get started →Willow
Seeing what it charges before you answer any medical questions
From $299/mo
Get started →GoodRx vs Hims: FAQ
Close alternatives to GoodRx and Hims
Or see the full category ranking.
Novo Nordisk A/S owns the Wegovy®, Ozempic® and Rybelsus® marks; Eli Lilly and Company owns Mounjaro® and Zepbound®. Every other product name and mark on this page belongs to whoever owns it. No pharmaceutical manufacturer is affiliated with GLP Watchdog. See trademark disclaimer.